Indonesia vs Mus: New or unknown treatment: Pulmonary, bacteriologically confirmed
Indonesia
376,117
in 2023
Mus
99
in 2023
Indonesia rank
2nd
Mus rank
1st
New or unknown treatment: Pulmonary, bacteriologically confirmed over time
- Indonesia
- Mus
How they compare
Indonesia currently reports 376,117 against 99 in Mus, a difference of 376,018.
That makes Indonesia's figure about 3,799.2 times Mus's.
Across all 11 years both countries report, Indonesia has been ahead every year.
Indonesia ranks 2nd and Mus ranks 1st of 197 countries.
Indonesia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Indonesia | Mus | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 205,135 | 113.57 | 205,021 | Indonesia |
| 2020s | 277,264 | 94.5 | 277,169 | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, Indonesia or Mus?
- Indonesia, at 376,117 against 99 in Mus as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between Indonesia and Mus?
- 376,018, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Mus?
- 11 years are reported by both, from 2013 to 2023.
- How do Indonesia and Mus rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- Indonesia ranks 2nd and Mus ranks 1st of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.